Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe.

ABSTRACT: Redox cancer therapeutics target the increased reliance on intracellular antioxidant systems and enhanced susceptibility to oxidant-induced stress of some cancer cells compared to normal cells. Many of these therapeutics are thought to perturb intracellular levels of the oxidant hydrogen peroxide (H₂O₂), a signaling molecule that modulates a number of different processes in human cells. However, fluorescent probes for this species remain limited in their ability to detect the small perturbations induced during successful treatments. We report a fluorescent sensor based upon human peroxiredoxin-2, which acts as the natural indicator of small H₂O₂ fluctuations in human cells. The new probe reveals peroxide-induced oxidation in human cells below the

SUBMITTER: Langford TF 

PROVIDER: S-EPMC6081480 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature